Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 22, Number 3—March 2016
Research

Changes in Predominance of Pulsed-Field Gel Electrophoresis Profiles of Bordetella pertussis Isolates, United States, 2000–2012

Pamela K. CassidayComments to Author , Tami H. Skoff, Selina Jawahir, and M. Lucia Tondella
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (P.K. Cassiday, T.H. Skoff, M.L. Tondella); Minnesota Department of Health, St. Paul, Minnesota, USA (S. Jawahir)

Main Article

Figure 4

Dendrogram of the predominant Bordetella pertussis pulsed-field gell electrophoresis (PFGE) profiles currently circulating in the United States. Clusters were determined by using unweighted pair group method with arithmetic mean (UPGMA) with 1% band tolerance and optimization settings. Box indicates area of band analysis (125 kb–450 kb). *Indicates the predominant B. pertussis PFGE profiles currently circulating in Europe, as reported by Advani et al. (12). In the area of band analysis, these pr

Figure 4. Dendrogram of the predominant Bordetella pertussis pulsed-field gell electrophoresis (PFGE) profiles currently circulating in the United States. Clusters were determined by using unweighted pair group method with arithmetic mean (UPGMA) with 1% band tolerance and optimization settings. Box indicates area of band analysis (125 kb–450 kb). *Indicates the predominant B. pertussis PFGE profiles currently circulating in Europe, as reported by Advani et al. (12). In the area of band analysis, these profiles (BpSR3, BpSR10, BpSR11, BpSR5, and BpSR12) were indistinguishable from US profiles CDC002, CDC010, CDC013, CDC046, and CDC082, respectively. Scale bar indicates percentage similarity.

Main Article

References
  1. Clark  TA, Messonnier  NE, Hadler  SC. Pertussis control: time for something new? Trends Microbiol. 2012;20:211–3. DOIPubMedGoogle Scholar
  2. Centers for Disease Control and Prevention. Pertussis (whooping cough)—fast facts. 2013 [cited 2014 Jan 24]. http://www.cdc.gov/pertussis/fast-facts.html
  3. Centers for Disease Control and Prevention. Pertussis epidemic—Washington, 2012. MMWR Morb Mortal Wkly Rep. 2012;61:517–22 .PubMedGoogle Scholar
  4. Misegades  LK, Winter  K, Harriman  K, Talarico  J, Messonnier  NE, Clark  TA, Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010. JAMA. 2012;308:2126–32. DOIPubMedGoogle Scholar
  5. Winter  K, Harriman  K, Zipprich  J, Schechter  R, Talarico  J, Watt  J, California pertussis epidemic, 2010. J Pediatr. 2012;161:1091–6. DOIPubMedGoogle Scholar
  6. Decker  MD, Edwards  KM, Steinhoff  MC, Rennels  MB, Pichichero  ME, Englund  JA, Comparison of 13 acellular pertussis vaccines: adverse reactions. Pediatrics. 1995;96:557–66 .PubMedGoogle Scholar
  7. Skoff  TH, Cohn  AC, Clark  TA, Messonnier  NE, Martin  SW. Early impact of the US Tdap vaccination program on pertussis trends. Arch Pediatr Adolesc Med. 2012;166:344–9 . DOIPubMedGoogle Scholar
  8. Centers for Disease Control and Prevention. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1997;46(RR-7):1–25 .PubMedGoogle Scholar
  9. Advani  A, Donnelly  D, Gustafsson  L, Hallander  HO. Changes of the Swedish Bordetella pertussis population in incidence peaks during an acellular pertussis vaccine period between 1997 and 2004. APMIS. 2007;115:299–310. DOIPubMedGoogle Scholar
  10. Advani  A, Gustafsson  L, Ahren  C, Mooi  FR, Hallander  HO. Appearance of Fim3 and ptxP3-Bordetella pertussis strains, in two regions of Sweden with different vaccination programs. Vaccine. 2011;29:3438–42. DOIPubMedGoogle Scholar
  11. Advani  A, Gustafsson  L, Carlsson  RM, Donnelly  D, Hallander  HO. Clinical outcome of pertussis in Sweden: association with pulsed-field gel electrophoresis profiles and serotype. APMIS. 2007;115:736–42. DOIPubMedGoogle Scholar
  12. Advani  A, Hallander  HO, Dalby  T, Krogfelt  KA, Guiso  N, Njamkepo  E, Pulsed-field gel electrophoresis analysis of Bordetella pertussis isolates circulating in Europe from 1998 to 2009. J Clin Microbiol. 2013;51:422–8. DOIPubMedGoogle Scholar
  13. Advani  A, Van der Heide  HG, Hallander  HO, Mooi  FR. Analysis of Swedish Bordetella pertussis isolates with three typing methods: characterization of an epidemic lineage. J Microbiol Methods. 2009;78:297–301. DOIPubMedGoogle Scholar
  14. Cassiday  P, Sanden  G, Heuvelman  K, Mooi  F, Bisgard  KM, Popovic  T. Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935–1999. J Infect Dis. 2000;182:1402–8. DOIPubMedGoogle Scholar
  15. Elomaa  A, Advani  A, Donnelly  D, Antila  M, Mertsola  J, Hallander  H, Strain variation among Bordetella pertussis isolates in Finland, where the whole-cell pertussis vaccine has been used for 50 years. J Clin Microbiol. 2005;43:3681–7. DOIPubMedGoogle Scholar
  16. Elomaa  A, He  QS, Minh  NNT, Mertsola  J. Pertussis before and after the introduction of acellular pertussis vaccines in Finland. Vaccine. 2009;27:5443–9. DOIPubMedGoogle Scholar
  17. Hallander  H, Advani  A, Riffelmann  M, von Konig  CH, Caro  V, Guiso  N, Bordetella pertussis strains circulating in Europe in 1999 to 2004 as determined by pulsed-field gel electrophoresis. J Clin Microbiol. 2007;45:3257–62. DOIPubMedGoogle Scholar
  18. Hallander  HO, Advani  A, Donnelly  D, Gustafsson  L, Carlsson  RM. Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs. J Clin Microbiol. 2005;43:2856–65. DOIPubMedGoogle Scholar
  19. Hardwick  TH, Cassiday  P, Weyant  RS, Bisgard  KM, Sanden  GN. Changes in predominance and diversity of genomic subtypes of Bordetella pertussis isolated in the United States, 1935 to 1999. Emerg Infect Dis. 2002;8:44–9. DOIPubMedGoogle Scholar
  20. Schmidtke  AJ, Boney  KO, Martin  SW, Skoff  TH, Tondella  ML, Tatti  KM. Population diversity among Bordetella pertussis isolates, United States, 1935–2009. Emerg Infect Dis. 2012;18:1248–55. DOIPubMedGoogle Scholar
  21. Pawloski  LC, Queenan  AM, Cassiday  PK, Lynch  AS, Harrison  M, Shang  W, Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the US. Clin Vaccine Immunol. 2014;21:119–25. DOIPubMedGoogle Scholar
  22. Caro  V, Njamkepo  E, Van Amersfoorth  SC, Mooi  FR, Advani  A, Hallander  HO, Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies. Microbes Infect. 2005;7:976–82. DOIPubMedGoogle Scholar
  23. Advani  A, Donnelly  D, Hallander  H. Reference system for characterization of Bordetella pertussis pulsed-field gel electrophoresis profiles. J Clin Microbiol. 2004;42:2890–7. DOIPubMedGoogle Scholar
  24. Tsang  RS, Shuel  M, Jamieson  FB, Drews  S, Hoang  L, Horsman  G, Pertactin-negative Bordetella pertussis strains in Canada: characterization of a dozen isolates based on a survey of 224 samples collected in different parts of the country over the last 20 years. Int J Infect Dis. 2014;28:65–9. DOIPubMedGoogle Scholar
  25. van Gent  M, Heuvelman  CJ, van der Heide  HG, Hallander  HO, Advani  A, Guiso  N, Analysis of Bordetella pertussis clinical isolates circulating in European countries during the period 1998–2012. Eur J Clin Microbiol Infect Dis. 2015;34:821–30.PubMedGoogle Scholar
  26. Mooi  FR, Van Der Mas  NAT, De Melker  H. Pertussis resurgence: waning immunity and pathogen adaptation—two sides of the same coin. Epidemiol Infect. 2014;142:685–94. DOIPubMedGoogle Scholar
  27. Martin  SW, Pawloski  L, Williams  M, Weening  K, DeBolt  C, Qin  X, Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage. Clin Infect Dis. 2015;60:223–7. DOIPubMedGoogle Scholar
  28. Bart  MJ, Harris  SR, Advani  A, Arakawa  Y, Bottero  D, Bouchez  V, Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. MBio. 2014;5:e01074–14. DOIPubMedGoogle Scholar
  29. Bisgard  KM, Christie  CD, Reising  SF, Sanden  GN, Cassiday  PK, Gomersall  C, Molecular epidemiology of Bordetella pertussis by pulsed-field gel electrophoresis profile: Cincinnati, 1989–1996. J Infect Dis. 2001;183:1360–7. DOIPubMedGoogle Scholar
  30. Bowden  KE, Williams  MM, Cassiday  PK, Milton  A, Pawloski  L, Harrison  M, Molecular epidemiology of the pertussis epidemic in Washington State in 2012. J Clin Microbiol. 2014;52:3549–57. DOIPubMedGoogle Scholar
  31. Gautom  RK. Rapid pulsed-field gel electrophoresis protocol for typing of Escherichia coli O157:H7 and other gram-negative organisms in 1 day. J Clin Microbiol. 1997;35:2977–80 .PubMedGoogle Scholar
  32. Swaminathan  B, Barrett  TJ, Hunter  SB, Tauxe  RV, Force  CDCPT. PulseNet: the molecular subtyping network for foodborne bacterial disease surveillance, United States. Emerg Infect Dis. 2001;7:382–9. DOIPubMedGoogle Scholar
  33. Hunter  PR, Gaston  MA. Numerical index of the discriminatory ability of typing systems: an application of Simpson’s index of diversity. J Clin Microbiol. 1988;26:2465–6 .PubMedGoogle Scholar
  34. Grundmann  H, Hori  S, Tanner  G. Determining confidence intervals when measuring genetic diversity and the discriminatory abilities of typing methods for microorganisms. J Clin Microbiol. 2001;39:4190–2. DOIPubMedGoogle Scholar
  35. Tenover  FC, Arbeit  RD, Goering  RV, Mickelsen  PA, Murray  BE, Persing  DH, Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233–9 .PubMedGoogle Scholar
  36. Stibitz  S, Yang  MS. Genomic plasticity in natural populations of Bordetella pertussis. J Bacteriol. 1999;181:5512–5 .PubMedGoogle Scholar
  37. Zeddeman  A, van Gent  M, Heuvelman  CJ, van der Heide  HG, Bart  MJ, Advani  A, Investigations into the emergence of pertactin-deficient Bordetella pertussis isolates in six European counries, 1996–2012. Euro Surveill. 2014;19:20881. DOIPubMedGoogle Scholar
  38. Hegerle  N, Guiso  N. Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines. Expert Rev Vaccines. 2014;13:1135–46. DOIPubMedGoogle Scholar

Main Article

Page created: February 18, 2016
Page updated: February 18, 2016
Page reviewed: February 18, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external